Phoenix Tissue Repair, Inc. clinical trials
A subsidiary of BridgeBio
The registry lists 3 studies whose lead sponsor is Phoenix Tissue Repair, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 21, 2022.
Registry sponsor names on this page
- Phoenix Tissue Repair, Inc.3 studies
Something wrong with this grouping? Tell us on the BridgeBio page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All BridgeBio studies →
- Extension Study to PTR-01-002 (A Study in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Patients Previously Treated With PTR-01)CompletedNCT05143190Phase 2
Sponsor listed in the registry: Phoenix Tissue Repair, Inc.
- A Study of PTR-01 in Recessive Dystrophic Epidermolysis BullosaCompletedNCT04599881Phase 2
Sponsor listed in the registry: Phoenix Tissue Repair, Inc.
- A Phase 1/2 Trial of PTR-01 in Adult Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)CompletedNCT03752905Phase 1/2
Sponsor listed in the registry: Phoenix Tissue Repair, Inc.